Close
Oct 16, 2026
- Reported revenue
- $5.46 bn Q2 2026
- Annual revenue growth
- 22.8% Q2 2026
- Operating margin
- 42.6% Q2 2026
- Reported P/E
- 42.55× 2026-10-14
1.Share price
Daily closes, adjusted for stock splits. Price return excludes dividends. Hover or tap to explore.
2.Company news
View allTexas Instruments earns more from its analog-chip business
The June-ended fiscal quarter combined stronger sales with a healthier operating margin, while lower gross equipment purchases eased the immediate investment burden.
3.Our verdict
Yes — we would buy at this price.
We like the essential jobs behind this business: controlling power, handling sound and helping electronics operate. Its broad analog portfolio is a powerful toolbox for equipment designers. From battery management to voltage regulation, Texas Instruments has a compelling opportunity to serve the practical building blocks of electronics.
Analysts’ average target is $324.71, 16.3% above the $279.12 reference price on Oct 15, 2026.
Analyst price targets · 12 months
Published analyst targets, compared with our dated share price.
- Average target
- $324.71
- Price potential
- +16.3%
- Analysts
- 36
- Low–high range
- $225.00$400.00
- Historical SPY reference · 5 years
- +11.6%
- Average target versus SPY hurdle
- 4.8 pp
- Buy threshold below
- $281.00
4.Investment case at publication
Texas Instruments puts the power-management toolbox to work
The analog-chip leader is earning more from its sales while spending less on equipment, but its manufacturing commitments and debt still demand discipline.
Texas Instruments has an attractive business in chips that manage power and process real-world signals. The reported fiscal quarter shows stronger revenue, profitability and cash generation against the same fiscal quarter of the prior year, without establishing which products drove those gains.
A broad analog and power-management portfolio gives Texas Instruments a compelling role across electronics applications.
Revenue, operating margin and reported diluted earnings improved against the same fiscal quarter of the prior year.
Lower gross equipment purchases helped quarterly cash after investment, while debt and competitive pressure remain important constraints.
5.Latest quarter
In the fiscal quarter ended in June, Texas Instruments reported higher revenue, operating margin and diluted earnings per share than in the same fiscal quarter of the prior year. The business earned more from each sales dollar, rather than simply expanding sales.
Reported-quarter operating cash flow also increased against the same fiscal quarter of the prior year. Gross cash purchases of property, plant and equipment declined against that same baseline, leaving more cash after those purchases.
| Metric | Period | Value |
|---|---|---|
| Reported revenue | Q2 2026 | $5.46 bn |
| Annual revenue growth | Q2 2026 | 22.8% |
| Reported operating income | Q2 2026 | $2.33 bn |
| Operating margin | Q2 2026 | 42.6% |
| Profit per share, after dilution | Q2 2026 | $2.14 |
6.The business
Texas Instruments makes chips that manage power and process real-world signals.
We like the essential jobs behind this business: controlling power, handling sound and helping electronics operate. Its broad analog portfolio is a powerful toolbox for equipment designers. From battery management to voltage regulation, Texas Instruments has a compelling opportunity to serve the practical building blocks of electronics.
Semiconductors dominate the business, while calculators provide a separate revenue stream. Texas Instruments also holds a leading position in processors and microcontrollers used across electronics applications.
7.Growth
Reported-quarter revenue increased against both the preceding fiscal quarter and the same fiscal quarter of the prior year. These comparisons establish stronger consolidated sales, but they do not identify whether shipment volumes, prices or product mix drove the result.
The power-management range includes switching regulators, power switches, voltage references and lighting products. That breadth creates several routes to customer demand, although a current product or end-market revenue breakdown is unavailable.
Revenue history
$ bnConsolidated reported quarterly revenue; compare the same fiscal quarter across years.
View chart data
| Period | Revenue ($ bn) |
|---|---|
| Q3 2023 | $4.53 |
| Q4 2023 | $4.08 |
| Q1 2024 | $3.66 |
| Q2 2024 | $3.82 |
| Q3 2024 | $4.15 |
| Q4 2024 | $4.01 |
| Q1 2025 | $4.07 |
| Q2 2025 | $4.45 |
| Q3 2025 | $4.74 |
| Q4 2025 | $4.42 |
| Q1 2026 | $4.83 |
| Q2 2026 | $5.46 |
8.Profitability
Operating margin measures the share of revenue left after operating costs. It improved in the reported fiscal quarter against both the preceding fiscal quarter and the same fiscal quarter of the prior year.
The latest annual filing describes a focus on efficiency and disciplined research, development and administrative spending. That provides useful context, but the reported quarterly figures do not isolate the contribution from efficiency, pricing or manufacturing activity.
Operating margin
%Reported consolidated operating income divided by revenue. Missing provider fields remain unavailable.
View chart data
| Period | Operating margin (%) |
|---|---|
| Q3 2023 | 41.75 |
| Q4 2023 | 37.6 |
| Q1 2024 | 35.13 |
| Q2 2024 | 32.65 |
| Q3 2024 | 37.44 |
| Q4 2024 | 34.36 |
| Q1 2025 | 32.54 |
| Q2 2025 | 35.14 |
| Q3 2025 | 35.07 |
| Q4 2025 | 33.3 |
| Q1 2026 | 37.47 |
| Q2 2026 | 42.6 |
9.Earnings
Reported diluted earnings per share increased against the same fiscal quarter of the prior year and the preceding fiscal quarter. This is the published reported measure, not an adjusted earnings figure.
Consolidated net income includes the effect of non-operating items, with other non-operating income reported separately. Operating margin is therefore the clearer measure for judging profitability within the core business.
| Metric | Period | Value |
|---|---|---|
| Other non-operating income | Q2 2026 | $0.05 bn |
| Reported consolidated net income | Q2 2026 | $1.98 bn |
| Average shares, including potential dilution | Q2 2026 | 0.92 bn shares |
Reported diluted EPS
$The published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred.
View chart data
| Period | Diluted EPS ($) |
|---|---|
| Q3 2023 | $1.85 |
| Q4 2023 | $1.5 |
| Q1 2024 | $1.2 |
| Q2 2024 | $1.22 |
| Q3 2024 | $1.47 |
| Q4 2024 | $1.28 |
| Q1 2025 | $1.28 |
| Q2 2025 | $1.41 |
| Q3 2025 | $1.48 |
| Q4 2025 | $1.25 |
| Q1 2026 | $1.68 |
| Q2 2026 | $2.14 |
10.Cash flow
For the reported fiscal quarter, operating cash flow increased and gross cash equipment and facility purchases declined against the same fiscal quarter of the prior year. Both changes contributed to higher cash remaining after those purchases.
For the trailing twelve months ended at June quarter-end, operating cash flow also exceeded gross cash purchases of property, plant and equipment. The resulting measure excludes asset-sale proceeds, intangible investments, leases and noncash commitments. It is not the issuer's defined free cash flow.
The latest annual filing identifies semiconductor manufacturing equipment and facilities as the main destinations for capital spending. These investments support the production base, but they also require sustained cash discipline.
| Metric | Period | Value |
|---|---|---|
| Cash generated by operations | TTM 2026-06-30 | $8.67 bn |
| Cash after investments | TTM 2026-06-30 | $5.36 bn |
| Cash generated by operations | Q2 2026 | $2.7 bn |
| Building and equipment investments | Q2 2026 | $0.51 bn |
| Cash after investments | Q2 2026 | $2.19 bn |
Cash generated versus cash invested
$ bnMassive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable.
View chart data
| Period | Operating cash flow ($ bn) | Gross cash PPE purchases ($ bn) | OCF less gross PPE purchases ($ bn) |
|---|---|---|---|
| Q3 2024 | $1.73 | $1.32 | $0.42 |
| Q4 2024 | $2 | $1.19 | $0.81 |
| Q1 2025 | $0.85 | $1.12 | -$0.27 |
| Q2 2025 | $1.86 | $1.31 | $0.56 |
| Q3 2025 | $2.19 | $1.2 | $0.99 |
| Q4 2025 | $2.25 | $0.93 | $1.33 |
| Q1 2026 | $1.52 | $0.68 | $0.84 |
| Q2 2026 | $2.7 | $0.51 | $2.19 |
11.Balance sheet
At June quarter-end, Texas Instruments held cash and short-term investments alongside current borrowings and noncurrent debt and capital lease obligations. Those liquid resources provide flexibility, but the borrowing commitments remain substantial.
The latest annual filing also describes dividends and share repurchases. Capital allocation must balance shareholder distributions with manufacturing investment and financing obligations.
| Metric | Period | Value |
|---|---|---|
| Cash and readily available funds | 2026-06-30 | $3.66 bn |
| Short-term investments | 2026-06-30 | $3.34 bn |
| Short-term debt | 2026-06-30 | $1.15 bn |
| Long-term debt and leases | 2026-06-30 | $12.9 bn |
12.Valuation
The current analyst targets and SPY comparison are shown in Our verdict.
View the current assessment13.What we are watching
Watch whether sales strength continues alongside healthy operating margins, and whether cash after gross equipment purchases remains resilient as investment requirements evolve.
Texas Instruments faces intense technology and pricing competition, including emerging Asian suppliers. Its latest annual filing also warns that geopolitical disruption can lengthen supplier lead times, restrict availability and raise costs. Restrictions on materials or processes may leave no reasonably priced substitute.